Viewing Study NCT03957733


Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-03-22 @ 8:49 AM
Study NCT ID: NCT03957733
Status: UNKNOWN
Last Update Posted: 2022-04-06
First Post: 2019-05-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
Sponsor: King Abdullah Medical City
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: 17-329
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER_GOV View
None OTHER View